Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk

被引：0
|
作者：
Pablo Serrano-Fernández
Tadeusz Dębniak
Bohdan Górski
Natalia Bogdanova
Thilo Dörk
Cezary Cybulski
Tomasz Huzarski
Tomasz Byrski
Jacek Gronwald
Dominika Wokołorczyk
Steven A. Narod
Jan Lubiński
机构：
[1] Pomeranian Medical University,International Hereditary Cancer Center, Department of Genetics and Pathology
[2] Hannover Medical School,Department of Obstetrics and Gynaecology
[3] Hannover Medical School,Department of Radiation Oncology
[4] NN Alexandrov Research Institute of Oncology and Medical Radiology,undefined
[5] Womens College Research Institute,undefined
来源：
Breast Cancer Research and Treatment | 2009年 / 117卷
关键词：
Breast cancer; Breast cancer; Gene interaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We studied the effects of BRCA2 and CHEK2 variants on breast cancer risk in two case-control series from Poland and Belarus. The missense BRCA2 variant T1915M was associated with a significant reduction in breast cancer risk (OR = 0.62; 95% CI 0.49–0.79; P = 0.0007). Modest increases of breast cancer risk were observed for the four analysed CHEK2 variants (I157T, 1100delC, IVS2 + 1G > A and del5395) (OR = 2.2; 95% 1.7–2.8; P = 0.0001). The highest risk was observed among women who carried both a BRCA2 and a CHEK2 variant (OR = 5.7; 95% CI 1.7–19; P = 0.006). We observed a statistically significant interaction effect between CHEK2 mutations and the BRCA2 substitution (P = 0.03). These data suggest that the BRCA2 T1915M polymorphism alone might be associated with a reduced risk of breast cancer, but among CHEK2 mutation carriers, it may lead to an unexpectedly high risk.
引用
收藏
页码：161 / 165
页数：4
相关论文
共 50 条
  • [21] BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases
    Mario Falchetti
    Ramona Lupi
    Piera Rizzolo
    Ketty Ceccarelli
    Ines Zanna
    Valentina Calò
    Stefania Tommasi
    Giovanna Masala
    Angelo Paradiso
    Alberto Gulino
    Giuseppe Giannini
    Antonio Russo
    Domenico Palli
    Laura Ottini
    Breast Cancer Research and Treatment, 2008, 110 : 161 - 167
  • [22] Population-based Estimates of contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
    Yadav, Siddhartha
    Boddicker, Nicholas J.
    Na, Jie
    Polley, Eric C.
    Hu, Chunling
    Hart, Steven N.
    Gnanaolivu, Rohan D.
    Larson, Nicole
    Dunn, Carolyn
    Holtegaard, Susan
    Huang, Huaizhi
    Teras, Lauren R.
    Patel, Alpa V.
    Lacey, James V., Jr.
    Neuhausen, Susan
    Bernstein, Leslie
    Martinez, Elena
    Haiman, Christopher
    Chen, Fei
    Ruddy, Kathryn
    Olson, Janet
    John, Esther
    Kurian, Allison W.
    Sandler, Dale P.
    O'Brien, Katie M.
    Taylor, Jack A.
    Weinberg, Clarice R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Zirpoli, Gary R.
    Goldgar, David E.
    Nathanson, Katherine L.
    Domchek, Susan
    Palmer, Julie R.
    Weitzel, Jeffrey
    Kraft, Peter
    Couch, Fergus J.
    CANCER RESEARCH, 2023, 83 (05)
  • [23] BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases
    Falchetti, Mario
    Lupi, Ramona
    Rizzolo, Piera
    Ceccarelli, Ketty
    Zanna, Ines
    Calo, Valentina
    Tommasi, Stefania
    Masala, Giovanna
    Paradiso, Angelo
    Gulino, Alberto
    Giannini, Giuseppe
    Russo, Antonio
    Palli, Domenico
    Ottini, Laura
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) : 161 - 167
  • [24] High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
    Irene Rainville
    Shanell Hatcher
    Eric Rosenthal
    Katie Larson
    Ryan Bernhisel
    Stephanie Meek
    Heidi Gorringe
    Erin Mundt
    Susan Manley
    Breast Cancer Research and Treatment, 2020, 180 : 503 - 509
  • [25] High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
    Rainville, Irene
    Hatcher, Shanell
    Rosenthal, Eric
    Larson, Katie
    Bernhisel, Ryan
    Meek, Stephanie
    Gorringe, Heidi
    Mundt, Erin
    Manley, Susan
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 503 - 509
  • [26] Genotyping of BRCA1, BRCA2, and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips
    Nasedkina, T. V.
    Gromyko, O. E.
    Emelyanova, M. A.
    Ignatova, E. O.
    Kazubskaya, T. P.
    Portnoi, S. M.
    Zasedatelev, A. S.
    Lyubchenko, L. N.
    MOLECULAR BIOLOGY, 2014, 48 (02) : 207 - 213
  • [27] Breast cancer risk associated with missense variants in BRCA2
    Yadav, Siddhartha
    Richardson, Marcy
    Karam, Rachid
    Boddicker, Nicholas J.
    Hu, Chunling
    Tecleab, Yohannes A.
    Kraft, Peter
    Weitzel, Jeffrey N.
    Domchek, Susan M.
    Nathanson, Katherine
    Couch, Fergus
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Genotyping of BRCA1, BRCA2, and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips
    T. V. Nasedkina
    O. E. Gromyko
    M. A. Emelyanova
    E. O. Ignatova
    T. P. Kazubskaya
    S. M. Portnoi
    A. S. Zasedatelev
    L. N. Lyubchenko
    Molecular Biology, 2014, 48 : 207 - 213
  • [29] CHEK2 variants: linking functional impact to cancer risk
    Boonen, Rick A. C. M.
    Vreeswijk, Maaike P. G.
    van Attikum, Haico
    TRENDS IN CANCER, 2022, 8 (09): : 759 - 770
  • [30] The risk of breast cancer in women with a CHEK2 mutation
    Cezary Cybulski
    Dominika Wokołorczyk
    Anna Jakubowska
    Tomasz Huzarski
    Tomasz Byrski
    Jacek Gronwald
    Tadeusz Dębniak
    Bohdan Górski
    Steven A Narod
    Jan Lubiński
    Hereditary Cancer in Clinical Practice, 10 (Suppl 1)
12345